The Bay Area is losing the data center race. Economists say that could be a good thing

The Bay Area is the runaway leader in artificial intelligence. But data centers, the physical architecture needed for AI ...

U.S. FDA approves JASCAYD® (nerandomilast) tablets for the treatment of progressive ...

Boehringer Ingelheim's JASCAYD® (nerandomilast) tablets has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of progressive pulmonary fibrosis (PPF) in adults.5 This ...